header
 |  |  |
 |  | |
 |  | |
Registration
Online Registration is Open!
Find Another IBC Event
Scientific Sponsor
Alternate Language Options
Alternate Language Options: 
Document Title
Agenda At-A-Glance
Agenda At-A-Glance
Agenda At-A-Glance
| Antibody Engineering | Antibody Therapeutics | |
| Sunday, December 7, 2008 | ||
| Afternoon | Pre-Conference Workshop: Microarrays and Nanotechnology for Antibody Discovery and Analysis | Purchase the all access pass to attend the Sunday workshop and Monday sessions of Antibody Engineering - AND SAVE! |
| 5:30 pm | The Antibody Society: General Session | |
| Monday, December 8, 2008 Exhibit Hall Hours: 6:00 pm - 7:30 pm | ||
| Morning | Session I: Keynote Presentations Michael S. Neuberger, Ph.D., Head, Division of Protein and Nucleic Acid Chemistry, MRC Laboratory of Molecular Biology, United Kingdom Sherie Morrison, Ph.D., Chair, Department of Microbiology, Immunology, & Molecular Genetics, University of California, Los Angeles | |
| 1:15 pm | Technology Workshops: Bio-Rad Laboratories, MedImmune | |
| 1:45 pm | Technology Workshops: Codon Devices, XOMA, Ltd. | |
| Afternoon | Session II: The Single-Chain Fv and its Fusion Proteins: 20 Years Old and Coming of Age | |
| 6:00 pm | Networking Cocktail Reception, Opening of Poster and Exhibit Hall | |
| Tuesday, December 9, 2008 Exhibit Hall Hours: 9:30 am - 7:45 pm | ||
| Morning | Session III: The Theory, Practice and Use of Libraries Based on Restricted amino Acid Sets | Start of Antibody Therapeutics Session I: Preclinical Development of Antibody Therapeutics Keynote Presentation: Benjamin P. Chen, Ph.D., Burrill & Company |
| 11:45 am | Technology Workshops: Antitope, Percivia LLC | |
| 12:15 pm | Networking Luncheon, Exhibit and Poster Viewing | |
| 1:45 pm | Technology Workshops: Attana AB, MorphoSys AG | |
| Afternoon | Session IV: Are Non-Antibody Scaffolds Really Any Better than Antibody Fragments? | Session II: Clinical Development of Cancer Therapeutics (1) Keynote Presentation: Robert O. Dillman, M.D., Hoag Cancer Center |
| 6:15 pm | Networking Cocktail Reception, Exhibit and Poster Viewing | |
| Wednesday, December 10, 2008 Exhibit Hall Hours: 9:45 am - 2:00 pm | ||
| Morning | Session V: Intrabodies Revisited | Session III: Clinical Development of Cancer Therapeutics (2) |
| 12:00 pm | Technology Workshop: BioWa | |
| 12:30 pm | Networking Luncheon, Last Chance for Exhibit and Poster Viewing | |
| Afternoon | Session VI: Novel Antibody Targets and Applications | Session IV: Clinical Development of Non-Cancer Therapeutics (1) |
| Thursday, December 11, 2008 | ||
| Morning | Session VII: Antibodies in a Complex Environment: Target Selection in Relation to Efficacy | Session V: Clinical Development of Non-Cancer Therapeutics (2) Antibody Therapeutics Ends |
| Afternoon | Session VIII: Mechanism of Antibody Action Revisited | |
footer
Copyright IBC Life Sciences, a part of Informa Life Sciences Group